Healthcare - Biotechnology - NASDAQ - US
$ 0.569
2.89 %
$ 65.7 M
Market Cap
-0.65
P/E
BALANCE SHEET
191 M
ASSETS
45 M
LIABILITIES
146 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
AlloVir, Inc.
| Current Assets | 188 M |
| Cash & Short-Term Investments | 184 M |
| Receivables | 206 K |
| Other Current Assets | 3.49 M |
| Non-Current Assets | 3.16 M |
| Long-Term Investments | 0 |
| PP&E | 2.19 M |
| Other Non-Current Assets | 974 K |
| Current Liabilities | 28.4 M |
| Accounts Payable | 6.76 M |
| Short-Term Debt | 21.6 M |
| Other Current Liabilities | 44 K |
| Non-Current Liabilities | 16.6 M |
| Long-Term Debt | 33.3 M |
| Other Non-Current Liabilities | -16.6 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 90.1 | 106.1 | 201.7 | 122.7 | 61.1 | 22.2 |
| Short Term Investments | 93.8 | 127.7 | 46.5 | 233.7 | 65.0 | 0 |
| Receivables | 0.2 | 0.2 | 50 K | 0.5 | 0.6 | 0.3 |
| Inventory | 0 | (0.2) | 50 K | (0.5) | 0 | 2.8 |
| Other Current Assets | 3.5 | 9.1 | 5.2 | 9.5 | 0.7 | 2.8 |
| Total Current Assets | 187.6 | 243.1 | 253.3 | 361.3 | 127.3 | 25.3 |
| PP&E | 2.2 | 32.6 | 31.3 | 9.5 | 12.1 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0.9 | 0.9 | 0 | 0 | 0 |
| Other Long Term Assets | 1.0 | 0.6 | 1.1 | 0 | 0 | 6 K |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 190.8 | 277.1 | 286.6 | 370.8 | 139.4 | 25.3 |
| LIABILITIES | ||||||
| Accounts Payable | 6.8 | 3.0 | 8.4 | 1.0 | 0.6 | 0.2 |
| Short Term Debt | 21.6 | 14.3 | 13.2 | 6.5 | 3.1 | 0 |
| Other Current Liabilities | 44 K | 6.9 | 15.3 | 4.9 | 5.4 | 0.9 |
| Total Current Liabilities | 28.4 | 24.3 | 37.9 | 12.3 | 9.1 | 3.7 |
| Long Term Debt | 33.3 | 56.4 | 47.0 | 10.9 | 8.7 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | (16.6) | (28.2) | (23.5) | (5.5) | 173.1 | 52.2 |
| Total Liabilities | 45.0 | 52.6 | 61.3 | 17.8 | 190.9 | 55.9 |
| EQUITY | ||||||
| Common Stock | 11 K | 9 K | 7 K | 7 K | 0 | 0 |
| Retained Earnings | (656.2) | (465.8) | (297.1) | (125.1) | (55.3) | (31.5) |
| Other Accumulative Comprehensive Income/Loss | 62 K | (0.5) | (0.2) | (0.1) | 68 K | 0 |
| Total Equity | 145.8 | 224.5 | 225.3 | 353.1 | (51.5) | (30.6) |
| Total Liabilities and Equity | 190.8 | 277.1 | 286.6 | 370.8 | 139.4 | 25.3 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 104.1 | 76.7 | 62.8 | 26.9 | 65.1 | 37.1 |